Bioconjugated magnetic nanoparticles for the detection of bacteria

Journal of Biomedical Nanotechnology

Volumn 9, Issue 12, 2013, Pages 1951-1961

  Chu, Yu W ^a   Engebretson, David A ^b   Carey, James R ^a  

^a NATIONAL UNIVERSITY OF KAOHSIUNG   (Taiwan)

^b OKLAHOMA CITY UNIVERSITY   (United States)

Author keywords

Bacteria detection; Colony forming units (CFU); Giant magnetoresistance (GMR) biosensor; Magnetic nanoparticles; Sepsis

Indexed keywords

BACTERIA DETECTION; COLONY FORMING UNITS; GIANT MAGNETORESISTANCES (GMR); MAGNETIC NANO-PARTICLES; SEPSIS;

BIOSENSORS; BLOOD; GIANT MAGNETORESISTANCE; MOLECULAR BIOLOGY; NANOPARTICLES;

BACTERIA;

BACTERIUM ANTIBODY; DAPTOMYCIN; MAGNETIC NANOPARTICLE; PEPTIDOGLYCAN; STREPTAVIDIN; VANCOMYCIN;

ANTIBODY AFFINITY; ANTIGEN RECOGNITION; BACTERIAL CELL WALL; BACTERIUM DETECTION; CHEMICAL STRUCTURE; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; CYCLOADDITION; DIELS ALDER REACTION; ENTEROCOCCUS FAECALIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; HYDROGEN BOND; LIMIT OF DETECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; OUTER MEMBRANE; PHOSPHOLIPID VESICLE; PROTEIN CONFORMATION; REVIEW; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE; WESTERN BLOTTING; X RAY CRYSTALLOGRAPHY;

ANTIBODIES; BACTERIA; BACTERIOLOGICAL TECHNIQUES; BIOSENSING TECHNIQUES; BLOOD-BORNE PATHOGENS; DAPTOMYCIN; HUMANS; MAGNETITE NANOPARTICLES; NANOCONJUGATES; VANCOMYCIN;

EID: 84888808796     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1701     Document Type: Review

References (76)

1. G. S. Martin, D. M. Mannino, S. Eaton, and M. Moss, The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546 (2003).
2. D. C. Angus, W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcilo, and M. R. Pinsky, Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome and associated costs of care. Critical Care Med. 29, 1303 (2001).
3. M. P. Weinstein, S. Mirrett, L. G. Reimer, M. L. Wilson, S. Smith-Elekes, C. R. Chuard, K. L. Joho, and L. B. Reller, Controlled evaluation of BacT/Alert standard aerobic and FAN aerobic blood culture bottles for detection of bacteremia and fungemia. J. Clin. Microbiol. 33, 978 (1995).
4. G. Funke and P. Funke-Kissling, Use of the BD PHOENIX automated microbiology system for direct identification and susceptibility testing of Gram-negative rods from positive blood cultures in a threephase trial. J. Clin. Microbiol. 42, 1466 (2004).
5. T. K. W. Ling, Z. K. Liu, and A. F. B. Cheng, Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of Gram-negative bacilli from positive blood cultures. J. Clin. Microbiol. 41, 4705 (2003).
6. D. S. Hansen, A. G. Jensen, N. Nørskov-Lauritsen, R. Skov, and B. Bruun, Direct identification and susceptibility testing of enteric bacilli from positive blood cultures using VITEK (GNI+/GNS-GA). Clin. Microbiol. Infect. 8, 38 (2002).
7. K. B. Waites, E. S. Brookings, S. A. Moser, and B. L. Zimmer, Direct susceptibility testing with positive BacT/Alert blood cultures by using microscan overnight and rapid panels. J. Clin. Microbiol. 36, 2052 (1998).
8. J. Barenfanger, C. Drake, and G. Kacich, Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J. Clin. Microbiol. 37, 1415 (1999).
9. G. V. Doern, R. Vautour, M. Gaudet, and B. Levy, Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J. Clin. Microbiol. 32, 1757 (1994).
10. H. Yang, H. Li, and X. Jiang, Detection of foodborne pathogens using bioconjugated nanomaterials. Microfluid. Nanofluid. 5, 571 (2008).
11. P. Tallury, A. Malhotra, L. M. Byrne, and S. Santra, Nanobioimaging and sensing of infectious diseases. Adv. Drug Delivery Rev. 62, 424 (2010).
12. X. Chi, D. Huang, Z. Zhao, Z. Zhou, Z. Yin, and J. Gao, Nanoprobes for in vitro diagnostics of cancer and infectious diseases. Biomaterials 33, 189 (2012).
13. J. Joo, C. Yim, D. Kwon, J. Lee, H. H. Shin, H. J. Cha, and S. Jeon, A facile and sensitive detection of pathogenic bacteria using magnetic nanoparticles and optical nanocrystal probes. Analyst 137, 3609 (2012).
14. L. Chen and J. Zhang, Bioconjugated magnetic nanoparticles for rapid capture of gram-positive bacteria. J. Biosens. Bioelectron. S11, 1 (2012).
15. S. Gautam, T. J. Gniadek, T. Kim, and D. A. Spiegel, Exterior design: Strategies for redecorating the bacterial surface with small molecules. Trends Biotechnol. 31, 258 (2013).
16. M. Caoa, Z. Lia, J. Wanga, W. Gea, T. Yuea, R. Lib, V. L. Colvinc, and W. W. Yu, Food related applications of magnetic iron oxide nanoparticles: Enzyme immobilization, protein purification, and food analysis. Trends Food Sci. Technol. 27, 47 (2012).
17. M.-H. Kim, I. Yamayoshi, S. Mathew, H. Lin, J. Nayfach, and S. I. Simon, Magnetic nanoparticle targeted hyperthermia of cutaneous staphylococcus aureus infection. Ann. Biomed. Eng. 41, 598 (2102).
18. P. C. Ray, S. A. Khan, A. K. Singh, D. Senapati, and Z. Fan, Nanomaterials for targeted detection and photothermal killing of bacteria. Chem. Soc. Rev. 41, 3193 (2012).
19. H. Gu, K. Xu, C. Xu, and B. Xu, Biofunctional magnetic nanoparticles for protein separation and pathogen detection. Chem. Comm. 941 (2006).
20. G. Pappert, M. Rieger, R. Niessner, and M. Seidel, Immunomagnetic nanoparticle-based sandwich chemiluminescence-ELISA for the enrichment and quantification of E. coli. Microchim. Acta 168, 1 (2010).
21. Z.-Q. Shen, J.-F. Wang, Z.-G. Qiu, M. Jin, X.-W. Wang, Z.-L. Chen, J.-W. Li, and F.-H. Cao, QCM immunosensor detection of Escherichia coli O157:H7 based on beacon immunomagnetic nanoparticles and catalytic growth of colloidal gold. Biosens. Bioelectron. 26, 3376 (2011).
22. E. B. Setterington and E. C. Alocilja, Rapid electrochemical detection of polyaniline-labeled Escherichia coli O157:H7. Biosens. Bioelectron. 26, 2208 (2011).
23. S. P. Ravindranath, L. J. Mauer, C. Deb-Roy, and J. Irudayaraj, Biofunctionalized magnetic nanoparticle integrated mid-infrared pathogen sensor for food matrixes. Anal. Chem. 81, 2840 (2009).
24. H. Gu, P.-L. Ho, K. W. T. Tsang, C.-W. Yu, and B. Xu, Using biofunctional magnetic nanoparticles to capture Gram-negative bacteria at an ultra-low concentration. Chem. Comm. 1966 (2003).
25. A. J. Kell, G. Stewart, S. Ryan, R. Peytavi, M. Boissinot, A. Huletsky, M. G. Bergeron, and B. Simard, Vancomycin-modified nanoparticles for efficient targeting and preconcentration of grampositive and gram-negative bacteria. ACS Nano 2, 1777 (2008).
26. H. J. Chung, T. Reiner, G. Budin, C. Min, M. Liong, D. Issadore, H. Lee, and R. Weissleder, Ubiquitous detection of Gram-positive bacteria with bioorthogonal magnetofluorescent nanoparticles. ACS Nano 5, 8834 (2011).
27. J. Gao, D. Liu, and Z. Wang, Screening lectin-binding specificity of bacterium by lectin microarray with gold nanoparticle probes. Anal. Chem. 82, 9240 (2010).
28. B. K. Hubbard and C. T. Walsh, Vancomycin assembly: Nature's way. Angew. Chem. Int. Edit. 42, 730 (2003).
29. D. H. Williams and B. Bardsley, The vancomycin group of antibiotics and the fight against resistant bacteria. Angew. Chem. Int. Edit. 38, 1172 (1999).
30. C. Walsh, Microbiology-deconstructing vancomycin. Science 284, 442 (1999).
31. M. Nieto and H. R. Perkins, Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex-formation with vancomycin. Biochem. J. 123, 789 (1971).
32. D. H. Williams, M. P. Williamson, D. W. Butcher, and S. J. Hammond, Detailed binding sites of the antibiotics vancomycin and ristocetin A: Determination of intermolecular distances in antibiotic/substrate complexes by use of the time-dependent NOE. J. Am. Chem. Soc. 105, 1332 (1983).
33. J. Rao, I. J. Colton, and G. M. Whitesides, Using capillary electrophoresis to study the electrostatic interactions involved in the association of D-Ala-D-Ala with vancomycin. J. Am. Chem. Soc. 119, 9336 (1997).
34. P. J. Loll, A. E. Bevivino, B. D. Korty, and P. H. Axelsen, Simultaneous recognition of a carboxylate-containing ligand and an intramolecular surrogate ligand in the crystal structure of an asymmetric vancomycin dimer. J. Am. Chem. Soc. 119, 1516 (1997).
35. J. Gao, L. Li, P. L. Ho, G. C. Mak, H. Gu, and B. Xu, Combining fluorescent probes and biofunctional magnetic nanoparticles for rapid detection of bacteria in human blood. Adv. Mater. 18, 3145 (2006).
36. H. Lee, E. Sun, D. Ham, and R. Weissleder, Chip-NMR biosensor for detection and molecular analysis of cells. Nat. Med. 14, 869 (2008).
37. H. Gu, P.-L. Ho, K. W. T. Tsang, L. Wang, and B. Xu, Using biofunctional magnetic nanoparticles to capture vancomycin-resistant enterococci and other Gram-positive bacteria at ultralow concentration. J. Am. Chem. Soc. 125, 15702 (2003).
38. Y. Wan, D. Zhang, and B. Hou, Determination of sulphate-reducing bacteria based on vancomycin-functionalised magnetic nanoparticles using a modification-free quartz crystal microbalance. Biosens. Bioelectron. 25, 1847 (2010).
39. Y.-S. Lin, P.-J. Tsai, M.-F. Weng, and Y.-C. Chen, Affinity capture using vancomycin-bound magnetic nanoparticles for the MALDI-MS analysis of bacteria. Anal. Chem. 77, 1753 (2005).
40. K. L. Tedesco and M. J. Rybak, Daptomycin. Pharmacotherapy 24, 41 (2004).
41. A. Raja, J. LaBonte, J. Lebbos, and P. Kirkpatrick. Daptomycin, Nat. Rev. Drug Discovery 2, 943 (2003).
42. B. I. Eisenstein, Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections. Expert Opin. Invest. Drugs 13, 1159 (2004).
43. P. Canepari, M. Boaretti, M. M. Lleó, and G. Satta, Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032). Antimicrob. Agents Chemother. 34, 1220 (1990).
44. J. H. Lakey and M. Ptak, Fluorescence indicates a calciumdependent interaction between the lipopeptide antibiotic LY 146032 and phospholipid membranes. Biochemistry 27, 4639 (1988).
45. J. A. Silverman, N. G. Perlmutter, and H. M. Shapiro, Correlation of daptomycin bactericidal activity and membrane depolarization in staphylococcus aureus. Antimicrob. Agents Chemother. 47, 2538 (2003).
46. D. Jung, A. Rozek, M. Okon, and R. E. W. Hancock, Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. Chem. Biol. 11, 949 (2004).
47. S. K. Straus and R. E. W. Hancock, Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: Comparison with cationic antimicrobial peptides and lipopeptides. Biochim. Biophys. Acta, Biomembr. 1758, 1215 (2006).
48. W. R. P. Scott, S.-B. Baek, D. Jung, R. E. W. Hancock, and S. K. Straus, NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles. Biochim. Biophys. Acta, Biomembr. 1768, 3116 (2007).
49. Y. Cheng, Y. Liu, J. Huang, K. Li, W. Zhang, Y. Xian, and L. Jin, Combining biofunctional magnetic nanoparticles and ATP bioluminescence for rapid detection of Escherichia coli. Talanta 77, 1332 (2009).
50. H. Lee, T.-J. Yoon, and R. Weissleder, Ultrasensitive detection of bacteria using core-shell nanoparticles and an NMR-filter system. Angew. Chem. Int. Edit. 48, 5657 (2009).
51. R. Maalouf, W. Hassen, C. Fournier-Wirth, J. Coste, and N. Jaffrezic-Renault, Comparison of two innovatives approaches for bacterial detection: Paramagnetic nanoparticles and self-assembled multilayer processes. Microchim. Acta 163, 157 (2008).
52. M. Varshney, Y. Li, B. Srinivasan, and S. Tung, A label-free, microfluidics and interdigitated array microelectrode-based impedance biosensor in combination with nanoparticles immunoseparation for detection of Escherichia coli O157:H7 in food samples. Sens. Actuators, B 128, 99 (2007).
53. C. Kaittanis, S. Santra, and J. M. Perez, Role of nanoparticle valency in the nondestructive magnetic-relaxation-mediated detection and magnetic isolation of cells in complex media. J. Am. Chem. Soc. 131, 12780 (2009).
54. 4 nanoparticles. Biosens. Bioelectron. 25, 1204 (2010).
55. X. Zeng, Z. Shen, and R. Mernaugh, Recombinant antibodies and their use in biosensors. Anal. Bioanal. Chem. 402, 3027 (2012).
56. A. Yokota, K. Tsumoto, M. Shiroishi, H. Kondo, and I. Kumagai, The Role of hydrogen bonding via interfacial water molecules in antigen-antibody complexation. J. Biol. Chem. 278, 5410 (2003).
57. M.Shiroishi, A.Yokota, K. Tsumoto, H.Kondo,Y. Nishimiya, K. Horii, M. Matsushimai, K. Ogasahara, K. Yutani, and I. Kumagai, Structural evidence for entropic contribution of salt bridge formation to a protein antigen-antibody interaction. J. Biol. Chem. 276, 23042 (2001).
58. L. Heinrich, N. Tissot, D. J. Hartmann, and R. Cohen, Comparison of the results obtained by ELISA and surface plasmon resonance for the determination of antibody affinity. J. Immunol. Methods 352, 13 (2010).
59. L. Tao and R. T. Kennedy, Measurement of antibody-antigen dissociation constants using fast capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis 18, 112 (1997).
60. B. Friguet, A. F. Chaffotte, L. Djavadi-Ohaniance, and M. E. Goldberg, Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods 77, 305 (1985).
61. J. P. Gosling, A decade of development in immunoassay methodology. Clin. Chem. 36, 1408 (1990).
62. S. M. Hsu, L. Raine, and H. Fanger, Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29, 577 (1981).
63. H. Towbin, T. StaehelinNt, and J. Gordon, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76, 4350 (1979).
64. O. Livnah, E. A. Bayer, M. Wilchek, and J. L. Sussman, Threedimensional structures of avidin and the avidin-biotin complex. Proc. Natl. Acad. Sci. U. S. A. 90, 5076 (1993).
65. A. Natarajan, C.-Y. Xiong, C. Gruettner, G. L. DeNardo, and S. J. DeNardo, Development of multivalent radioimmunonanoparticles for cancer imaging and therapy. Cancer Biother. Radiopharm. 23, 82 (2008).
66. I. Koh, R. Hong, R. Weissleder, and L. Josephson, Nanoparticletarget interactions parallel antibody-protein interactions. Anal. Chem. 81, 3618 (2009).
67. S. Ryan, A. J. Kell, H. van Faassen, L.-L. Tay, B. Simard, R. MacKenzie, M. Gilbert, and J. Tanha, Single-domain antibodynanoparticles: Promising architectures for increased Staphylococcus aureus detection specificity and sensitivity. Bioconjugate Chem. 20, 1966 (2009).
68. N. K. Devaraj, R. Upadhyay, J. B. Haun, S. A. Hilderbrand, and R. Weissleder, Fast and sensitive pretargeted labeling of cancer cellsthrough a tetrazine/trans-cyclooctene cycloaddition. Angew. Chem. Int. Ed. 48, 7013 (2009).
69. G. A. Prinz, Magnetoelectronics. Science 282, 1660 (1998).
70. S. A. Wolf, D. D. Awschalom, R. A. Buhrman, J. M. Daughton, S. von Molnár, M. L. Roukes, A. Y. Chtchelkanova, and D. M. Treger, Spintronics: A spin-based electronics vision for the future. Science 294, 1488 (2001).
71. R. S. Gaster, L. Xu, S.-J. Han, R. J. Wilson, D. A. Hall, S. J. Osterfeld, H. Yu, and S. X. Wang, Quantification of protein interactions and solution transport using high-density GMR sensor arrays. Nat. Nano 6, 314 (2011).
72. R. S. Gaster, D. A. Hall, and S. X. Wang, NanoLAB: An ultraportable, handheld diagnostic laboratory for global health. Lab Chip 11, 950 (2011).
73. D. A. Hall, R. S. Gaster, T. Lin, S. J. Osterfeld, S. Han, B. Murmann, and S. X. Wang, GMR biosensor arrays: A system perspective. Biosens. Bioelectron. 25, 2051 (2010).
74. R. S. Gaster, D. A. Hall, C. H. Nielsen, S. J. Osterfeld, H. Yu, K. E. Mach, R. J. Wilson, B. Murmann, J. C. Liao, S. S. Gambhir, and S. X. Wang, Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat. Med. 15, 1327 (2009).
75. A. C. Mak, S. J. Osterfeld, H. Yu, S. X. Wang, R. W. Davis, O. A. Jejelowo, and N. Pourmand, Sensitive giant magnetoresistive-based immunoassay for multiplex mycotoxin detection. Biosens. Bioelectron. 25, 1635 (2010).
76. R. S. Gaster, D. A. Hall, and S. X. Wang, Autoassembly protein arrays for analyzing antibody cross-reactivity. Nano Lett. 11, 2579 (2011).